S100A2 and pancreatic adenocarcinoma: The PAAD-IRGS comprised of S100P, S100A2 and MMP12 had an outstanding diagnostic value (Fig. 4D) and accurately predicted the prognosis for PAAD patients (Fig. 5A,B).